With thorough expertise in the field of influenza virus production systems, VirNext offers panoply of solutions and deliverables, ranging from specific vaccine antigens to whole infectious or inactivated viruses. Various human and animal influenza strains and several production systems are proposed.
VirNext provides complete characterization of each deliverable (including complete genome sequence), with quantitatively and qualitatively evaluated
batches (see Influenza Services). Packaging is custom made, including high concentration/volume viral stocks or small-volume aliquots, depending on the customer’s
needs. In-house storage at -80°C is also possible.
VirNext has an extensive virus collection, including respiratory syncitial virus (RSV), parainfluenza virus (PIV), adenovirus, coronavirus (SARS-CoV-2), rhinovirus and human metapneumovirus (hMPV) among others. Please contact us for more information on production and evaluation services.